Tumor DNA From Tumor In Situ Fluid Reveals Mutation Landscape of Minimal Residual Disease After Glioma Surgery and Risk of Early Recurrence
The recurrence of glioma is a difficult problem in clinical treatment. The molecular markers of primary tumors after resection cannot fully represent the characteristics of recurrent tumors. Here, abundant tumor DNA was detected in tumor in situ fluid (TISF). We report that TISF-derived tumor DNA (T...
Saved in:
Published in | Frontiers in oncology Vol. 11; p. 742037 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
11.10.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The recurrence of glioma is a difficult problem in clinical treatment. The molecular markers of primary tumors after resection cannot fully represent the characteristics of recurrent tumors. Here, abundant tumor DNA was detected in tumor
in situ
fluid (TISF). We report that TISF-derived tumor DNA (TISF-DNA) can detect genomic changes in recurrent tumors and facilitate recurrence risk analysis, providing valuable information for diagnosis and prognosis. The tumor DNA in TISF is more representative and sensitive than that in cerebrospinal fluid. It reveals the mutational landscape of minimal residual disease after glioma surgery and the risk of early recurrence, contributing to the clinical management and clinical research of glioma patients. |
---|---|
AbstractList | The recurrence of glioma is a difficult problem in clinical treatment. The molecular markers of primary tumors after resection cannot fully represent the characteristics of recurrent tumors. Here, abundant tumor DNA was detected in tumor in situ fluid (TISF). We report that TISF-derived tumor DNA (TISF-DNA) can detect genomic changes in recurrent tumors and facilitate recurrence risk analysis, providing valuable information for diagnosis and prognosis. The tumor DNA in TISF is more representative and sensitive than that in cerebrospinal fluid. It reveals the mutational landscape of minimal residual disease after glioma surgery and the risk of early recurrence, contributing to the clinical management and clinical research of glioma patients. The recurrence of glioma is a difficult problem in clinical treatment. The molecular markers of primary tumors after resection cannot fully represent the characteristics of recurrent tumors. Here, abundant tumor DNA was detected in tumor in situ fluid (TISF). We report that TISF-derived tumor DNA (TISF-DNA) can detect genomic changes in recurrent tumors and facilitate recurrence risk analysis, providing valuable information for diagnosis and prognosis. The tumor DNA in TISF is more representative and sensitive than that in cerebrospinal fluid. It reveals the mutational landscape of minimal residual disease after glioma surgery and the risk of early recurrence, contributing to the clinical management and clinical research of glioma patients. |
Author | Liu, Gang Wu, Shuang Bu, Yage Yan, Zhaoyue Gao, Yushuai Wang, Meiyun Li, Tianxiao Bu, Xingyao Yu, Jinliang Zemmar, Ajmal Chen, Zhongcan Xu, Sensen Zhang, Qianqian Hernesniemi, Juha Deng, Kaiyuan Sheng, Zhiyuan Gu, Jianjun Bu, Chaojie |
AuthorAffiliation | 5 Department of Medical Imaging, Henan Provincial People’s Hospital, The People’s Hospital of Zhengzhou University , Zhengzhou , China 2 Department of Neurosurgery, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital , Zhengzhou , China 7 Department of Center for Clinical Single Cell Biomedicine, Clinical Research Center, Department of Oncology, Henan Provincial People’s Hospital, The People’s Hospital of Zhengzhou University , Zhengzhou , China 1 Department of Neurosurgery, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital , Zhengzhou , China 4 Juha International Center for Neurosurgery, Henan Provincial People’s Hospital , Zhengzhou , China 6 Henan Provincial Key Laboratory for Imaging Diagnosis and Research of Neurological Diseases, Henan Provincial People’s Hospital, The People’s Hospital of Zhengzhou University , Zhengzhou , China 3 Juha International Central Laboratory of Neurosurgery, Henan Provincia |
AuthorAffiliation_xml | – name: 4 Juha International Center for Neurosurgery, Henan Provincial People’s Hospital , Zhengzhou , China – name: 7 Department of Center for Clinical Single Cell Biomedicine, Clinical Research Center, Department of Oncology, Henan Provincial People’s Hospital, The People’s Hospital of Zhengzhou University , Zhengzhou , China – name: 2 Department of Neurosurgery, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital , Zhengzhou , China – name: 1 Department of Neurosurgery, Children’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital , Zhengzhou , China – name: 3 Juha International Central Laboratory of Neurosurgery, Henan Provincial People’s Hospital , Zhengzhou , China – name: 5 Department of Medical Imaging, Henan Provincial People’s Hospital, The People’s Hospital of Zhengzhou University , Zhengzhou , China – name: 6 Henan Provincial Key Laboratory for Imaging Diagnosis and Research of Neurological Diseases, Henan Provincial People’s Hospital, The People’s Hospital of Zhengzhou University , Zhengzhou , China |
Author_xml | – sequence: 1 givenname: Jinliang surname: Yu fullname: Yu, Jinliang – sequence: 2 givenname: Zhiyuan surname: Sheng fullname: Sheng, Zhiyuan – sequence: 3 givenname: Shuang surname: Wu fullname: Wu, Shuang – sequence: 4 givenname: Yushuai surname: Gao fullname: Gao, Yushuai – sequence: 5 givenname: Zhaoyue surname: Yan fullname: Yan, Zhaoyue – sequence: 6 givenname: Chaojie surname: Bu fullname: Bu, Chaojie – sequence: 7 givenname: Jianjun surname: Gu fullname: Gu, Jianjun – sequence: 8 givenname: Yage surname: Bu fullname: Bu, Yage – sequence: 9 givenname: Kaiyuan surname: Deng fullname: Deng, Kaiyuan – sequence: 10 givenname: Sensen surname: Xu fullname: Xu, Sensen – sequence: 11 givenname: Zhongcan surname: Chen fullname: Chen, Zhongcan – sequence: 12 givenname: Qianqian surname: Zhang fullname: Zhang, Qianqian – sequence: 13 givenname: Ajmal surname: Zemmar fullname: Zemmar, Ajmal – sequence: 14 givenname: Juha surname: Hernesniemi fullname: Hernesniemi, Juha – sequence: 15 givenname: Meiyun surname: Wang fullname: Wang, Meiyun – sequence: 16 givenname: Gang surname: Liu fullname: Liu, Gang – sequence: 17 givenname: Tianxiao surname: Li fullname: Li, Tianxiao – sequence: 18 givenname: Xingyao surname: Bu fullname: Bu, Xingyao |
BookMark | eNpVkl9vFCEUxSemxtbadx959GVX_swM8GKyabt1k60mbU18IwxcVuoMrDDTZD-DX1rWaYzlhXvhnN8l4bytTkIMUFXvCV4yJuRHF4NZUkzJktcUM_6qOqOU1QtZs-8n_9Wn1UXOj7istsEEszfVKas5oS3BZ9Xvh2mICV19WaF1igOa201A936c0LqfvEV38AS6z-h2GvXoY0BbHWw2eg8oOnTrgx90X1TZ26kUVz6DzoBWboSEbnofB43up7SDdEDFie58_nl0XuvUH4rPTClBMPCueu3KHLh43s-rb-vrh8vPi-3Xm83larswNZPjomPcSeJa3jTSia6tG4plZxptrCCYdq0Q2BDMDbadYwxjAw0W1FhdayexYOfVZubaqB_VPpXnp4OK2qu_BzHtlE6jNz0oIA0Qwa2wktbcGCGF0YBbx7l2VtPC-jSz9lM3gDUQxqT7F9CXN8H_ULv4pERTc8pxAXx4BqT4a4I8qsFnA32vA8QpK9rI8mmSE1KkeJaaFHNO4P6NIVgdI6GOkVDHSKg5EuwPSqir2A |
CitedBy_id | crossref_primary_10_1093_noajnl_vdac037 crossref_primary_10_1016_j_jlb_2024_100142 crossref_primary_10_1002_cam4_6327 crossref_primary_10_1002_ctm2_956 crossref_primary_10_1016_j_isci_2023_107528 crossref_primary_10_3389_fonc_2023_1238607 crossref_primary_10_3171_2022_9_FOCUS22430 |
Cites_doi | 10.1093/annonc/mdz042 10.1038/ng.3590 10.1038/nrc.2017.7 10.1038/s41586-019-0882-3 10.3389/fonc.2021.584988 10.1126/scitranslmed.aaf6219 10.1007/s12022-017-9491-6 10.7150/thno.21687 10.1158/2159-8290.CD-ND2020-010 10.1158/2159-8290.CD-17-0716 10.1001/jamaoncol.2019.1838 10.1038/nature22364 10.1038/s41467-020-19175-0 10.1200/JCO.2016.66.6487 10.1007/s00401-018-1936-6 10.1038/ncomms9839 10.1038/nrneurol.2015.171 10.1038/s41571-020-00457-x 10.1053/j.gastro.2019.10.039 10.3322/caac.21613 10.1158/2159-8290.CD-20-1474 10.1073/pnas.1511694112 10.1186/s13073-020-00770-1 10.1038/s41586-019-1775-1 10.1126/scitranslmed.aab0021 |
ContentType | Journal Article |
Copyright | Copyright © 2021 Yu, Sheng, Wu, Gao, Yan, Bu, Gu, Bu, Deng, Xu, Chen, Zhang, Zemmar, Hernesniemi, Wang, Liu, Li and Bu 2021 Yu, Sheng, Wu, Gao, Yan, Bu, Gu, Bu, Deng, Xu, Chen, Zhang, Zemmar, Hernesniemi, Wang, Liu, Li and Bu |
Copyright_xml | – notice: Copyright © 2021 Yu, Sheng, Wu, Gao, Yan, Bu, Gu, Bu, Deng, Xu, Chen, Zhang, Zemmar, Hernesniemi, Wang, Liu, Li and Bu 2021 Yu, Sheng, Wu, Gao, Yan, Bu, Gu, Bu, Deng, Xu, Chen, Zhang, Zemmar, Hernesniemi, Wang, Liu, Li and Bu |
DBID | AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fonc.2021.742037 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2234-943X |
EndPage | 742037 |
ExternalDocumentID | oai_doaj_org_article_e15e187d8d9247cc898cae06f77afda2 10_3389_fonc_2021_742037 |
GrantInformation_xml | – fundername: ; grantid: 192102310126, 201601016 |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EJD EMOBN GROUPED_DOAJ GX1 HYE IAO IEA IHR IHW KQ8 M48 M~E OK1 PGMZT RNS RPM 7X8 5PM |
ID | FETCH-LOGICAL-c439t-b37f91f67559f8b645209bc5acd8102b6880c107c0dbf3300ce5082cda4af9083 |
IEDL.DBID | RPM |
ISSN | 2234-943X |
IngestDate | Tue Dec 17 15:24:17 EST 2024 Tue Sep 17 21:08:08 EDT 2024 Fri Oct 25 09:13:46 EDT 2024 Thu Nov 21 21:23:05 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c439t-b37f91f67559f8b645209bc5acd8102b6880c107c0dbf3300ce5082cda4af9083 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors share senior authorship Edited by: Khan Iftekharuddin, Old Dominion University, United States These authors have contributed equally to this work Reviewed by: Giselle Lopez, Duke University, United States; Ayca Erşen Danyeli, Associate Professor, İstanbul, Turkey This article was submitted to Neuro-Oncology and Neurosurgical Oncology, a section of the journal Frontiers in Oncology |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547270/ |
PMID | 34712610 |
PQID | 2590109711 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e15e187d8d9247cc898cae06f77afda2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8547270 proquest_miscellaneous_2590109711 crossref_primary_10_3389_fonc_2021_742037 |
PublicationCentury | 2000 |
PublicationDate | 2021-10-11 |
PublicationDateYYYYMMDD | 2021-10-11 |
PublicationDate_xml | – month: 10 year: 2021 text: 2021-10-11 day: 11 |
PublicationDecade | 2020 |
PublicationTitle | Frontiers in oncology |
PublicationYear | 2021 |
Publisher | Frontiers Media S.A |
Publisher_xml | – sequence: 0 name: Frontiers Media S.A – name: Frontiers Media S.A |
References | Escudero (B23) 2020; 11 Nicholson (B3) 2021; 11 Lau (B17) 2020; 12 Wang (B25) 2015; 112 Wang (B5) 2016; 48 Garcia-Murillas (B6) 2019; 5 Azad (B16) 2020; 158 Barthel (B4) 2019; 576 Pan (B19) 2019; 137 Miller (B20) 2019; 565 Chaudhuri (B14) 2017; 7 Westphal (B22) 2015; 11 Ignatiadis (B8) 2021; 18 Garcia-Murillas (B12) 2015; 7 Tie (B13) 2016; 8 Pentsova (B24) 2016; 34 (B7) 2020; 10 Shepherd (B2) 2019; 30 Abbosh (B15) 2017; 545 Wan (B18) 2017; 17 Jiang (B11) 2017; 7 Cracolici (B10) 2018; 29 De Mattos-Arruda (B21) 2015; 6 Sheng (B9) 2021; 11 Tan (B1) 2020; 70 |
References_xml | – volume: 30 year: 2019 ident: B2 article-title: Searching for the Needle in the Haystack: Deconvoluting the Evolutionary Dynamics of Residual Disease in Human Glioblastoma publication-title: Ann Oncol doi: 10.1093/annonc/mdz042 contributor: fullname: Shepherd – volume: 48 year: 2016 ident: B5 article-title: Clonal Evolution of Glioblastoma Under Therapy publication-title: Nat Genet doi: 10.1038/ng.3590 contributor: fullname: Wang – volume: 17 year: 2017 ident: B18 article-title: Liquid Biopsies Come of Age: Towards Implementation of Circulating Tumour DNA publication-title: Nat Rev Cancer doi: 10.1038/nrc.2017.7 contributor: fullname: Wan – volume: 565 year: 2019 ident: B20 article-title: Tracking Tumour Evolution in Glioma Through Liquid Biopsies of Cerebrospinal Fluid publication-title: Nature doi: 10.1038/s41586-019-0882-3 contributor: fullname: Miller – volume: 11 year: 2021 ident: B9 article-title: Characterizing the Genomic Landscape of Brain Glioma With Circulating Tumor DNA From Tumor In Situ Fluid publication-title: Front Oncol doi: 10.3389/fonc.2021.584988 contributor: fullname: Sheng – volume: 8 start-page: 346ra92 year: 2016 ident: B13 article-title: Circulating Tumor DNA Analysis Detects Minimal Residual Disease and Predicts Recurrence in Patients With Stage II Colon Cancer publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aaf6219 contributor: fullname: Tie – volume: 29 start-page: 9 year: 2018 ident: B10 article-title: Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas With Unique Molecular Signatures publication-title: Endocr Pathol doi: 10.1007/s12022-017-9491-6 contributor: fullname: Cracolici – volume: 7 year: 2017 ident: B11 article-title: Mutational Landscape of cfDNA Identifies Distinct Molecular Features Associated With Therapeutic Response to First-Line Platinum-Based Doublet Chemotherapy in Patients With Advanced NSCLC publication-title: Theranostics doi: 10.7150/thno.21687 contributor: fullname: Jiang – volume: 10 start-page: OF7 year: 2020 ident: B7 article-title: MRD May Predict Relapse in NSCLC publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-ND2020-010 – volume: 7 year: 2017 ident: B14 article-title: Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-17-0716 contributor: fullname: Chaudhuri – volume: 5 year: 2019 ident: B6 article-title: Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2019.1838 contributor: fullname: Garcia-Murillas – volume: 545 year: 2017 ident: B15 article-title: Phylogenetic ctDNA Analysis Depicts Early-Stage Lung Cancer Evolution publication-title: Nature doi: 10.1038/nature22364 contributor: fullname: Abbosh – volume: 11 start-page: 5376 year: 2020 ident: B23 article-title: Circulating Tumour DNA From the Cerebrospinal Fluid Allows the Characterisation and Monitoring of Medulloblastoma publication-title: Nat Commun doi: 10.1038/s41467-020-19175-0 contributor: fullname: Escudero – volume: 34 year: 2016 ident: B24 article-title: Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid publication-title: J Clin Oncol doi: 10.1200/JCO.2016.66.6487 contributor: fullname: Pentsova – volume: 137 start-page: 297 year: 2019 ident: B19 article-title: Molecular Profiling of Tumors of the Brainstem by Sequencing of CSF-Derived Circulating Tumor DNA publication-title: Acta Neuropathol doi: 10.1007/s00401-018-1936-6 contributor: fullname: Pan – volume: 6 start-page: 8839 year: 2015 ident: B21 article-title: Cerebrospinal Fluid-Derived Circulating Tumour DNA Better Represents the Genomic Alterations of Brain Tumours Than Plasma publication-title: Nat Commun doi: 10.1038/ncomms9839 contributor: fullname: De Mattos-Arruda – volume: 11 year: 2015 ident: B22 article-title: Circulating Biomarkers for Gliomas publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2015.171 contributor: fullname: Westphal – volume: 18 start-page: 297 year: 2021 ident: B8 article-title: Liquid Biopsy Enters the Clinic - Implementation Issues and Future Challenges publication-title: Nat Rev Clin Oncol doi: 10.1038/s41571-020-00457-x contributor: fullname: Ignatiadis – volume: 158 start-page: 494 year: 2020 ident: B16 article-title: Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.10.039 contributor: fullname: Azad – volume: 70 start-page: 299 year: 2020 ident: B1 article-title: Management of Glioblastoma: State of the Art and Future Directions publication-title: CA Cancer J Clin doi: 10.3322/caac.21613 contributor: fullname: Tan – volume: 11 year: 2021 ident: B3 article-title: Diffuse Glioma Heterogeneity and Its Therapeutic Implications publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-20-1474 contributor: fullname: Nicholson – volume: 112 year: 2015 ident: B25 article-title: Detection of Tumor-Derived DNA in Cerebrospinal Fluid of Patients With Primary Tumors of the Brain and Spinal Cord publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1511694112 contributor: fullname: Wang – volume: 12 start-page: 72 year: 2020 ident: B17 article-title: Detection of ctDNA in Plasma of Patients With Clinically Localised Prostate Cancer Is Associated With Rapid Disease Progression publication-title: Genome Med doi: 10.1186/s13073-020-00770-1 contributor: fullname: Lau – volume: 576 year: 2019 ident: B4 article-title: Longitudinal Molecular Trajectories of Diffuse Glioma in Adults publication-title: Nature doi: 10.1038/s41586-019-1775-1 contributor: fullname: Barthel – volume: 7 start-page: 302ra133 year: 2015 ident: B12 article-title: Mutation Tracking in Circulating Tumor DNA Predicts Relapse in Early Breast Cancer publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aab0021 contributor: fullname: Garcia-Murillas |
SSID | ssj0000650103 |
Score | 2.3681889 |
Snippet | The recurrence of glioma is a difficult problem in clinical treatment. The molecular markers of primary tumors after resection cannot fully represent the... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database |
StartPage | 742037 |
SubjectTerms | circulating tumor DNA glioma progression Oncology precision medicine spatiotemporal heterogeneity tumor in-situ fluid |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLojzE8pKRuHAItfP2caEsBbE9bFupt8gej0VEN0G7m_4J_jQz8RZtTlw45jFy4hl7vtF4vhHiHYSsIreqEocBkzxkeVJnGSSIgKXhEAG5OHl5Xp5d5d-ui-uDVl98JizSA8eJO0FdoK4rX3uKFCqA2tRgUZWhqmzwNu6-Kj0IpuIeXHADg5iXpCjMnIS-Y8bCVH-gYFBx2_MDPzTS9U8w5vSE5IHLWTwSD_dYUc7jNx6Le9g9FveX-2z4E_H7clj3G3l6PpeLTb-W8fJrJy_a3SAXN0Pr5QpvCQpu5XKIOXf5nWt7-dST7INctl27piFWuB2LsuRpzNfIObcOl19u2n5t5UUsnZYkKVft9idLjsTIJAcjvxPgU3G1-Hz56SzZN1dIgDDILnFZFYwOFC8UJtSO85vKOCgs-Jrm05W0sIFiQ1DehSxTCpCwXAre5jYYAm7PxFHXd_hcyBKZThSd96nJA6TOak-ymFbaGoB8Jt7fTXXzK3JoNBR7sFoaVkvDammiWmbiI-vi73vMfj3eIJto9jbR_MsmZuLtnSYbWi2cArEd9sO2SbnUlmmz9ExUExVPRpw-6dofI-92XeSE9tSL__GJL8UD_mv2glq_Eke7zYCvCd7s3JvRkv8AFHT8eQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWgSFUvqHyJhYKMxIVDShIncXJAaEtZCiI9bLtSb5Zjj0vEbgLJBsFv4E93JkmBSD1xzMfIiif2vKfxvGHspXFCYlj1vQIceJETkZcKYTwAA0lGFAGoODk_TU5W0aeL-OJvefQ4ge2N1I76Sa2a9eHP77_e4oJ_Q4wT4-1rV1ckRhgGh8jzfCFvszshxkU64JWPYH_Yl2NqajDkKm803GO7AjdrJBX-JEz1av4TCDo9QPlPRFrss7sjlOTzwff32C2o7rPdfEyWP2C_z7tN3fDj0zlfNPWGD5cfK35Wbju-WHel5Uv4gUix5Xk3pOT5Zyr9pUNRvHY8L6tyg0Msoe1rtvjxkM7hc-oszj-sy3qj-dlQWc3Rki_L9itZ9rrJaGd6-ScDD9lq8f783Yk39l7wDEKUrVcI6bLAIZ2IM5cWlP70s8LE2tgUMUmR4Lo3SB2NbwsnhO8bQKgXGqsj7TLEdY_YTlVX8JjxBEhtFAprwyxyJix0YNEWQhnozJhoxl5dT7X6NkhsKKQm5CFFHlLkITV4aMaOyBd_3iNx7P5G3Vyqca0pCGIIUmlTi-RSGpNmqdHgJ05K7awOZ-zFtScVLibKkOgK6q5VIVXikqpWMGNy4uLJiNMnVfmll-VO4wjBoP_kvy2fsj36VIqMQXDAdrZNB88Q8myL5_2ffAVA9gPD priority: 102 providerName: Scholars Portal |
Title | Tumor DNA From Tumor In Situ Fluid Reveals Mutation Landscape of Minimal Residual Disease After Glioma Surgery and Risk of Early Recurrence |
URI | https://search.proquest.com/docview/2590109711 https://pubmed.ncbi.nlm.nih.gov/PMC8547270 https://doaj.org/article/e15e187d8d9247cc898cae06f77afda2 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBbaHoZdhj2x7FFowC47OLH89jFrl3bDXAxpC-RmSBTVGYvtIon3J_anR9rJUF93keEHIduUTH4m-UmIj-DClMyq7xl06EUujLwsDMFDBExyhgjIxcnFVXJ5G31bxasjER9qYfqkfTDVtFnX06b62edW3tcwO-SJzX4UZ1kckdn1Z8fimLYPIPrw-Y157YIhJEkALJ-5tmGywkBNCQf6Ia-7F9I3mbCDP7JGPWn_yNMc50k-MDyLp-LJ3mOU8-HOnokjbJ6LR8U-Jv5C_Lnp6nYjz6_mcrFpaznsfm3kdbXr5GLdVVYu8Tc5hFtZdEPkXX7nCl_OfZKtk0XVVDV1scRtX5olz4eojZzzAuLyYl21tZbXQwG1JEm5rLa_WLKnRyY56FmeAF-K28WXm7NLb7_Eggfkiew8E6YuV45QQ5y7zHCU088NxBpsRq6HSWh6AyFE8K1xYej7gOTRBWB1pF1O7tsrcdK0Db4WMkEmFUVjbZBHDgKjlSVZDFKlc4BoIj4dXnV5PzBplIRAWEMla6hkDZWDhibiM-vi33XMgd0faDd35X4klKhiVFlqM0sYMgXI8gw0-olLU-2sDibiw0GTJc0ZDoToBttuWwZccMvkWWoi0pGKRz2Oz9Bg7Nm394PvzX9LvhWP-VHZACr1TpzsNh2-J89mZ077PwLUXqwUtUWUnfZj-y-0qf6x |
link.rule.ids | 230,314,727,780,784,864,885,2102,24318,27924,27925,53791,53793 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9NADB4tiwRcEE9RnoPEhUPaTCavOZZdSheaCnW70t5G84SIJlm1DX-CP42dtGhz5ZiHlYc9Y3-y_ZmQD8bzDNxqGGjnXRB7Hgc55yZwzrhUIERw2JxcLNP5Vfz1Ork-IcmxF6Yr2je6HNebalyXP7vaypvKTI51YpPvxVmexOB2w8kdcjfhmWC3QHq_ASc4vaBPSgIEExPf1EhXGLExIMGQ4-Q9DrsyoIdw4I862v5BrDmslLzlemaPyMNDzEin_bs9JieufkLuFYes-FPyZ91WzZaeL6d0tm0q2h9e1PSy3Ld0tmlLS1fuN4SEO1q0fe6dLrDHF6ufaONpUdZlBY9YuV3XnEXP-7wNneIIcfplUzaVopd9CzUFSboqd79QsiNIBjnT8TwZ94xczT6vz-bBYchCYCAW2QeaZ14wD7ghET7XmOcMhTaJMjaH4EOnsMANYEQTWu05D0PjIKaLjFWx8gICuOfktG5q94LQ1CGtqNPWRiL2JtKKWZB1UcaUMCYekY_HXy1vei4NCRgENSRRQxI1JHsNjcgn1MW_-5AFuzvRbH_Igy1IxxLH8szmFlBkZkwucqNcmPosU96qaETeHzUpYdVgKkTVrml3MsKWW6TPYiOSDVQ8eOLwCphjx799ML-X_y35jtyfr4uFXFwsv70iD_Cz0R0y9pqc7retewNxzl6_7az6L0mE_0Y |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9NADB7BIq24IJ6iPAeJC4e0SSbPY9kSdmFTrbq70t5GkxkPRDRJ1Tb8Cf40dpKi5soxDysPe8b-ZPszYx-1FTG6VdcpwIITWBE4iRDaAdAQpQQRgJqT82V0fht8uwvvjkZ9dUX7uiin9bqa1uXPrrZyU-nZoU5sdpWfJWGAbtedbYyd3WcPQoFGdgTU-004pAkGfWISYVg6s01NlIW-N0U06AqavidwZ0YE4Y58UkfdP4o3x9WSR-4ne8weDXEjn_fv94Tdg_opO82HzPgz9uemrZotXyznPNs2Fe8PL2p-Xe5bnq3b0vAV_MawcMfzts-_80vq86UKKN5Ynpd1WeEjVrDrGrT4os_d8DmNEedf12VTKX7dt1FzlOSrcveLJDuSZJTTHdeThufsNvtyc3buDIMWHI3xyN4pRGxTzyJ2CFObFJTrdNNCh0qbBAOQIsJFrhEnatcUVgjX1YBxna-NCpRNMYh7wU7qpoaXjEdA1KJQGOOngdV-oTyDsuDHnkq1Dibs0-FXy03PpyERh5CGJGlIkoZkr6EJ-0y6-HcfMWF3J5rtDznYgwQvBC-JTWIQScZaJ2miFbiRjWNljfIn7MNBkxJXDqVDVA1Nu5M-td0ShZY3YfFIxaMnjq-gSXYc3IMJvvpvyffs9GqRycuL5ffX7CF9NXlEz3vDTvbbFt5iqLMv3nVG_RfpiQBo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tumor+DNA+From+Tumor+In+Situ+Fluid+Reveals+Mutation+Landscape+of+Minimal+Residual+Disease+After+Glioma+Surgery+and+Risk+of+Early+Recurrence&rft.jtitle=Frontiers+in+oncology&rft.au=Yu%2C+Jinliang&rft.au=Sheng%2C+Zhiyuan&rft.au=Wu%2C+Shuang&rft.au=Gao%2C+Yushuai&rft.date=2021-10-11&rft.pub=Frontiers+Media+S.A&rft.eissn=2234-943X&rft.volume=11&rft_id=info:doi/10.3389%2Ffonc.2021.742037&rft_id=info%3Apmid%2F34712610&rft.externalDBID=PMC8547270 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon |